Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.

Hamadeh F, Awadallah A, Meyerson HJ, Beck RC.

Cytometry B Clin Cytom. 2019 Jan 5. doi: 10.1002/cyto.b.21761. [Epub ahead of print]

PMID:
30614203
2.

Compound Heterozygosity for Hb D-Ibadan (HBB: c.263C>A) and Hb C (HBB: c.19G>A).

Kundrapu S, Janaki N, Meyerson HJ.

Hemoglobin. 2018 Jul;42(4):269-271. doi: 10.1080/03630269.2018.1523799. Epub 2019 Jan 3.

PMID:
30604644
3.

Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia.

Covut F, Gupta D, Pinto R, Dambrosio N, El Jurdi N, Meyerson H, Ueda M, Kolk M, Creger R, Metheny L, Cooper BW, Caimi PF, Malek E, Otegbeye F, Lazarus HM, De Lima M, Tomlinson BK.

Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):73-82. doi: 10.1016/j.clml.2018.11.001. Epub 2018 Nov 12.

PMID:
30528848
4.

SLAMF7 (CD319/CS1) is expressed in plasmablastic lymphoma and is a potential diagnostic marker and therapeutic target.

Shi J, Bodo J, Zhao X, Durkin L, Goyal T, Meyerson H, Hsi ED.

Br J Haematol. 2019 Apr;185(1):145-147. doi: 10.1111/bjh.15393. Epub 2018 May 22. No abstract available.

PMID:
29785767
5.

A multicolour flow cytometric assay for c-MYC protein in B-cell lymphoma.

Alayed K, Schweitzer K, Awadallah A, Shetty S, Turakhia S, Meyerson H.

J Clin Pathol. 2018 Oct;71(10):906-915. doi: 10.1136/jclinpath-2018-205075. Epub 2018 May 16.

PMID:
29769234
6.

Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.

Gupta A, Palassery R, Meyerson H, Ahuja S, Matloub Y.

J Pediatr Hematol Oncol. 2019 Apr;41(3):229-232. doi: 10.1097/MPH.0000000000001168.

PMID:
29668547
7.

Topical Hypochlorite and Skin Acidification Improves Erythroderma of Omenn Syndrome.

Wat M, Olicker A, Meyerson H, Nedorost S, Paller AS, Cooper K.

Pediatrics. 2018 Apr;141(Suppl 5):S408-S411. doi: 10.1542/peds.2017-1249.

8.

Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model.

Metheny L, Eid S, Lingas K, Ofir R, Pinzur L, Meyerson H, Lazarus HM, Huang AY.

Front Med (Lausanne). 2018 Feb 22;5:37. doi: 10.3389/fmed.2018.00037. eCollection 2018.

9.

Factor XII and uPAR upregulate neutrophil functions to influence wound healing.

Stavrou EX, Fang C, Bane KL, Long AT, Naudin C, Kucukal E, Gandhi A, Brett-Morris A, Mumaw MM, Izadmehr S, Merkulova A, Reynolds CC, Alhalabi O, Nayak L, Yu WM, Qu CK, Meyerson HJ, Dubyak GR, Gurkan UA, Nieman MT, Sen Gupta A, Renné T, Schmaier AH.

J Clin Invest. 2018 Mar 1;128(3):944-959. doi: 10.1172/JCI92880. Epub 2018 Jan 29.

10.

Juvenile myelomonocytic leukemia with prominent CD141+ myeloid dendritic cell differentiation.

Meyerson H, Awadallah A, Blidaru G, Osei E, Schlegelmilch J, Egler R, Abu-Arja R, Ding H.

Hum Pathol. 2017 Oct;68:147-153. doi: 10.1016/j.humpath.2017.03.025. Epub 2017 Apr 13.

PMID:
28414089
11.

Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.

Starr AG, Caimi PF, Fu P, Massoud MR, Meyerson H, Hsi ED, Mansur DB, Cherian S, Cooper BW, De Lima MJG, Lazarus HM, Gerson SL, Jagadeesh D, Smith MR, Dean RM, Pohlman BL, Hill BT, William BM.

Hematology. 2017 Aug;22(7):405-411. doi: 10.1080/10245332.2017.1279842. Epub 2017 Jan 20.

PMID:
28105889
12.

Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells.

Metheny L 3rd, Eid S, Lingas K, Reese J, Meyerson H, Tong A, de Lima M, Huang AY.

Hematol Med Oncol. 2016;1(1):25-29. Epub 2016 Oct 20.

13.

Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.

Starr AG, Caimi PF, Fu P, Massoud MR, Meyerson H, Hsi ED, Mansur DB, Cherian S, Cooper BW, De Lima MJ, Lazarus HM, Gerson SL, Jagadeesh D, Smith MR, Dean RM, Pohlman BL, Hill BT, William BM.

Br J Haematol. 2016 Oct;175(2):275-280. doi: 10.1111/bjh.14228. Epub 2016 Jul 22.

PMID:
27443247
14.

Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.

Starr AG, Caimi PF, Fu P, Massoud MR, Meyerson H, Hsi ED, Mansur DB, Cherian S, Singh AD, Cooper BW, De Lima MJ, Lazarus HM, Gerson SL, Jagadeesh D, Smith MR, Dean RM, Pohlman BL, Hill BT, William BM.

Br J Haematol. 2016 May;173(3):404-12. doi: 10.1111/bjh.13975. Epub 2016 Mar 8.

PMID:
26953041
15.

Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignancies.

Liu X, Zheng H, Li X, Wang S, Meyerson HJ, Yang W, Neel BG, Qu CK.

Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):984-9. doi: 10.1073/pnas.1508535113. Epub 2016 Jan 11.

16.

A critical role for alpha-synuclein in development and function of T lymphocytes.

Shameli A, Xiao W, Zheng Y, Shyu S, Sumodi J, Meyerson HJ, Harding CV, Maitta RW.

Immunobiology. 2016 Feb;221(2):333-40. doi: 10.1016/j.imbio.2015.10.002. Epub 2015 Oct 20.

17.

CD1c(+) myeloid dendritic cells in myeloid neoplasia.

Meyerson HJ, Osei E, Schweitzer K, Blidaru G, Edinger A, Schlegelmilch J, Awadallah A, Goyal T.

Cytometry B Clin Cytom. 2016 Jul;90(4):337-48. doi: 10.1002/cyto.b.21332. Epub 2015 Dec 22.

18.

CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.

Gong S, Osei ES, Kaplan D, Chen YH, Meyerson H.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1613-21. eCollection 2015.

19.

Contemplating the etiology of chronic urticaria and the implications of current guidelines.

Sterbank J, Kim Y, Toller-Artis E, Barcena M, Bose S, Meyerson H, Hostoffer R, Tcheurekdjian H.

Ann Allergy Asthma Immunol. 2015 Jun;114(6):526-7. doi: 10.1016/j.anai.2014.12.025. Epub 2015 Mar 31. No abstract available.

PMID:
25840498
20.

Mycobacterium avium Complex Infection in a Patient with Sickle Cell Disease and Severe Iron Overload.

Shemisa K, Jafferjee N, Thomas D, Jacobs G, Meyerson HJ.

Case Rep Infect Dis. 2014;2014:405323. doi: 10.1155/2014/405323. Epub 2014 Dec 4.

21.

A rare presentation of EBV⁺ mucocutaneous ulcer that led to a diagnosis of hypogammaglobulinemia.

Kleinman S, Jhaveri D, Caimi P, Cameron R, Lemonovich T, Meyerson H, Hostoffer R, Tcheurekdjian H.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):810-2. doi: 10.1016/j.jaip.2014.07.009. Epub 2014 Sep 10. No abstract available.

PMID:
25439381
22.

Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease.

Xiao W, Shameli A, Harding CV, Meyerson HJ, Maitta RW.

Immunobiology. 2014 Nov;219(11):836-44. doi: 10.1016/j.imbio.2014.07.014. Epub 2014 Jul 22.

23.

A prolonged incubation period in zosteriform Leishmania panamensis.

Gogol-Tagliaferro A, Swender D, Chernin L, Tcheurekdjian H, Meyerson H, Hostoffer R.

Cutis. 2014 Feb;93(2):E5-6. No abstract available.

PMID:
24605357
24.

Case study interpretation--Fort Lauderdale: Case 1.

Balog A, Meyerson H.

Cytometry B Clin Cytom. 2015 Nov-Dec;88(6):396-9. doi: 10.1002/cyto.b.21150. Epub 2014 Jan 31. No abstract available.

25.

Case Study Interpretation - Fort Lauderdale: Case 1.

Balog A, Meyerson H.

Cytometry B Clin Cytom. 2013 Dec 17. doi: 10.1002/cytob.21150. [Epub ahead of print] No abstract available.

26.

CD177 expression on neutrophils: in search of a clonal assay for myeloid neoplasia by flow cytometry.

Meyerson HJ, Osei E, Schweitzer K, Blidaru G, Edinger A, Balog A.

Am J Clin Pathol. 2013 Nov;140(5):658-69. doi: 10.1309/AJCPDFBEBQZW1OI7.

PMID:
24124144
27.

Prion protein regulates iron transport by functioning as a ferrireductase.

Singh A, Haldar S, Horback K, Tom C, Zhou L, Meyerson H, Singh N.

J Alzheimers Dis. 2013;35(3):541-52. doi: 10.3233/JAD-130218.

28.

Hypereosinophilic syndrome associated with regulatory T-cell disruption as a complication of stem cell transplantation.

Kersey-Barrett T, Glick A, Wald D, Meyerson H, Tcheurekdjian H.

J Investig Allergol Clin Immunol. 2012;22(6):453-5. No abstract available. Erratum in: J Investig Allergol Clin Immunol. 2013;23(1):73.

29.

Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.

Meyerson HJ, Awadallah A, Pavlidakey P, Cooper K, Honda K, Miedler J.

Mod Pathol. 2013 Jan;26(1):32-43. doi: 10.1038/modpathol.2012.124. Epub 2012 Aug 24.

30.

The functional duality of HoxB4 in hematopoietic reconstituting cells.

Kaplan D, Kaye N, Liu F, Fu P, Margevicius S, Meyerson HJ, Lazarus HM.

Cytometry A. 2013 Jan;83(1):127-33. doi: 10.1002/cyto.a.22059. Epub 2012 Apr 20.

31.

Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing.

Simmons DP, Wearsch PA, Canaday DH, Meyerson HJ, Liu YC, Wang Y, Boom WH, Harding CV.

J Immunol. 2012 Apr 1;188(7):3116-26. doi: 10.4049/jimmunol.1101313. Epub 2012 Feb 27.

32.

NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.

Meyerson HJ, Blidaru G, Edinger A, Osei E, Schweitzer K, Fu P, Ho L.

Am J Clin Pathol. 2012 Jan;137(1):39-50. doi: 10.1309/AJCP6VDBL4BRXRQA.

PMID:
22180477
33.

Myelomastocytic Leukemia With t(8;21) in a 3-year-old Child.

Intzes S, Wiersma S, Meyerson HJ.

J Pediatr Hematol Oncol. 2011 Dec;33(8):e372-5. doi: 10.1097/MPH.0b013e3182329b80.

PMID:
22042288
34.

Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.

Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, Margevicius S, Fu P, van Heeckeren W, Lazarus HM, Cooper BW, Gerson SL, Barr P, Tse WW, Curtis C, Fanning LR, Creger RJ, Carlson-Barko JM, Laughlin MJ.

Bone Marrow Transplant. 2012 Jul;47(7):924-33. doi: 10.1038/bmt.2011.195. Epub 2011 Oct 17.

35.

Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.

Xu D, Liu X, Yu WM, Meyerson HJ, Guo C, Gerson SL, Qu CK.

J Exp Med. 2011 Sep 26;208(10):1977-88. doi: 10.1084/jem.20110450. Epub 2011 Sep 19.

36.

Marginal zone B cell lymphomas with extensive plasmacytic differentiation are neoplasms of precursor plasma cells.

Meyerson HJ, Bailey J, Miedler J, Olobatuyi F.

Cytometry B Clin Cytom. 2011 Mar;80(2):71-82. doi: 10.1002/cyto.b.20571. Epub 2010 Nov 20.

37.

High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow.

Woost PG, Solchaga LA, Meyerson HJ, Shankey TV, Goolsby CL, Jacobberger JW.

Blood. 2011 Apr 14;117(15):e131-41. doi: 10.1182/blood-2010-10-316224. Epub 2011 Feb 17.

38.

Erdheim-chester disease associated with marginal zone lymphoma and monoclonal proteinemia.

Pavlidakey PG, Mohanty A, Kohler LJ, Meyerson HJ.

Case Rep Hematol. 2011;2011:941637. doi: 10.1155/2011/941637. Epub 2011 Oct 20.

39.

A practical approach to the flow cytometric detection and diagnosis of T-cell lymphoproliferative disorders.

Meyerson HJ.

Lab Hematol. 2010 Sep;16(3):32-52. doi: 10.1532/LH96.10001. Review.

PMID:
20858587
40.

Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.

Tu Z, Li Q, Chou HS, Hsieh CC, Meyerson H, Peters MG, Bu H, Fung JJ, Qian S, Lu L, Lin F.

Immunobiology. 2011 Apr;216(4):528-34. doi: 10.1016/j.imbio.2010.08.004. Epub 2010 Aug 19.

41.

Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL.

Kaplan D, Meyerson HJ, Li X, Drasny C, Liu F, Costaldi M, Barr P, Lazarus HM.

Cytometry B Clin Cytom. 2010 Mar;78(2):115-22. doi: 10.1002/cyto.b.20506.

42.

Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport.

Singh A, Kong Q, Luo X, Petersen RB, Meyerson H, Singh N.

PLoS One. 2009 Jul 1;4(7):e6115. doi: 10.1371/journal.pone.0006115.

43.

Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.

Mwanda WO, Orem J, Fu P, Banura C, Kakembo J, Onyango CA, Ness A, Reynolds S, Johnson JL, Subbiah V, Bako J, Wabinga H, Abdallah FK, Meyerson HJ, Whalen CC, Lederman MM, Black J, Ayers LW, Katongole-Mbidde E, Remick SC.

J Clin Oncol. 2009 Jul 20;27(21):3480-8. doi: 10.1200/JCO.2008.18.7641. Epub 2009 May 26.

44.

A case of recurrent pseudolymphomatous folliculitis: A mimic of cutaneous lymphoma.

Kwon EJ, Kristjansson AK, Meyerson HJ, Fedele GM, Tung RC, Sellheyer K, Tuthill RJ, Honda KS, Gilliam AC, McNiff JM.

J Am Acad Dermatol. 2009 Jun;60(6):994-1000. doi: 10.1016/j.jaad.2008.10.010.

PMID:
19467371
45.

CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells.

Reineks EZ, Osei ES, Rosenberg A, Auletta J, Meyerson HJ.

Cytometry B Clin Cytom. 2009 Jul;76(4):237-48. doi: 10.1002/cyto.b.20469.

46.

A case of CD30+ nasal natural killer/T-cell lymphoma.

Ferenczi K, Summers P, Aubert P, Cooper B, Meyerson H, Cooper KD, Honda K.

Am J Dermatopathol. 2008 Dec;30(6):567-71. doi: 10.1097/DAD.0b013e318184bc3f.

PMID:
19033930
47.

Flow cytometry for the diagnosis of mycosis fungoides.

Meyerson HJ.

G Ital Dermatol Venereol. 2008 Feb;143(1):21-41. Review.

PMID:
18833049
48.

The foreign body reaction in T-cell-deficient mice.

Rodriguez A, Macewan SR, Meyerson H, Kirk JT, Anderson JM.

J Biomed Mater Res A. 2009 Jul;90(1):106-13. doi: 10.1002/jbm.a.32050.

49.

Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites.

Rodriguez A, Meyerson H, Anderson JM.

J Biomed Mater Res A. 2009 Apr;89(1):152-9. doi: 10.1002/jbm.a.31939.

50.

Instability of self-assembled monolayers as a model material system for macrophage/FBGC cellular behavior.

Jones JA, Qin LA, Meyerson H, Kwon IK, Matsuda T, Anderson JM.

J Biomed Mater Res A. 2008 Jul;86(1):261-8. doi: 10.1002/jbm.a.31660.

Supplemental Content

Loading ...
Support Center